EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Calcineurin inhibition rescues alloantigen-specific central memory T cell subsets that promote chronic GVHD

Yewei Wang, Md Ashik Ullah, Olivia G Waltner, Shruti S Bhise, Kathleen S Ensbey, Christine R Schmidt, Samuel Rw Legg, Tomoko Sekiguchi, Ethan L Nelson, Rachel D Kuns, Nicole S Nemychenkov, Erden Atilla und 11 weitere

Journal of Clinical Investigation · 03.06.2024 · 134 (11)

DOI: 10.1172/jci170125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 03.06.2024. Verfasst von Yewei Wang und 22 weiteren Autor:innen. Beteiligte Einrichtung: Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Graft vs Host Disease, Isoantigens, Calcineurin Inhibitors, Memory T Cells. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NCI NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Calcineurin inhibitors (CNIs) constitute the backbone of modern acute graft-versus-host disease (aGVHD) prophylaxis regimens but have limited efficacy in the prevention and treatment of chronic GVHD (cGVHD). We investigated the effect of CNIs on immune tolerance after stem cell transplantation with discovery-based single-cell gene expression and T cell receptor (TCR) assays of clonal immunity in tandem with traditional protein-based approaches and preclinical modeling. While cyclosporin and tacrolimus suppressed the clonal expansion of CD8 + T cells during GVHD, alloreactive CD4 + T cell clusters were preferentially expanded. Moreover, CNIs mediated reversible dose-dependent suppression of T cell activation and all stages of donor T cell exhaustion. Critically, CNIs promoted the expansion of both polyclonal and TCR-specific alloreactive central memory CD4 + T cells (T CM ) with high self-renewal capacity that mediated cGVHD following drug withdrawal. In contrast to posttransplant cyclophosphamide (PT-Cy), CSA was ineffective in eliminating IL-17A–secreting alloreactive T cell clones that play an important role in the pathogenesis of cGVHD. Collectively, we have shown that, although CNIs attenuate aGVHD, they paradoxically rescue alloantigen-specific T CM , especially within the CD4 + compartment in lymphoid and GVHD target tissues, thus predisposing patients to cGVHD. These data provide further evidence to caution against CNI-based immune suppression without concurrent approaches that eliminate alloreactive T cell clones.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft vs Host DiseaseIsoantigensCalcineurin InhibitorsMemory T CellsAnimalsMiceChronic DiseaseTacrolimusCD4-Positive T-LymphocytesCyclosporineFemaleCD8-Positive T-LymphocytesT-Lymphocyte Subsets

Stichwörter der Autor:innen

Bone marrow transplantationImmunologyT cellsTransplantation

Substanzen

IsoantigensCalcineurin InhibitorsTacrolimusCyclosporine

Autor:innen und Institutionen

  • Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Department of Hematology, The Second Xiangya Hospital, Central South University, Changsha, China.
  • QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
  • Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA.
  • Envoi Pathology, Brisbane, Queensland, Australia.

Förderung

  • NHLBI NIH HHS
  • NCI NIH HHS
  • NIAID NIH HHS
  • NCATS NIH HHS
  • NIH

Zitieren

APA

Wang, Y., Ullah, M. A., Waltner, O. G., Bhise, S. S., Ensbey, K. S., Schmidt, C. R., Legg, S. R., Sekiguchi, T., Nelson, E. L., Kuns, R. D., Nemychenkov, N. S., Atilla, E., Yeh, A. C., Takahashi, S., Boiko, J. R., Varelias, A., Blazar, B. R., Koyama, M., Minnie, S. A., …, & Hill, G. R. (2024). Calcineurin inhibition rescues alloantigen-specific central memory T cell subsets that promote chronic GVHD. Journal of Clinical Investigation, 134(11). https://doi.org/10.1172/jci170125

Vancouver

Wang Y, Ullah MA, Waltner OG, Bhise SS, Ensbey KS, Schmidt CR, et al. Calcineurin inhibition rescues alloantigen-specific central memory T cell subsets that promote chronic GVHD. Journal of Clinical Investigation. 2024;134(11). doi:10.1172/jci170125

BibTeX
@article{Wang2024,
  author = {Wang, Yewei and Ullah, Md Ashik and Waltner, Olivia G and Bhise, Shruti S and Ensbey, Kathleen S and Schmidt, Christine R and Legg, Samuel Rw and Sekiguchi, Tomoko and Nelson, Ethan L and Kuns, Rachel D and Nemychenkov, Nicole S and Atilla, Erden and Yeh, Albert C and Takahashi, Shuichiro and Boiko, Julie R and Varelias, Antiopi and Blazar, Bruce R and Koyama, Motoko and Minnie, Simone A and Clouston, Andrew D and Furlan, Scott N and Zhang, Ping and Hill, Geoffrey R},
  title = {Calcineurin inhibition rescues alloantigen-specific central memory T cell subsets that promote chronic GVHD},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  volume = {134},
  number = {11},
  doi = {10.1172/jci170125}
}
Kostenlos starten →